Cardiology Update

JANUARY 14, 2024

The perplexing landscape of angina with nonobstructive coronary arteries (ANOCA) encompasses diverse pathophysiological entities, including coronary microvascular disease (CMD), coronary artery spasm, and the enigmatic myocardial bridging (MB). Traditionally deemed benign, MBs, marked by the intramyocardial passage of an epicardial artery, are increasingly implicated in chronic angina and acute ischemic events.

Exercise 119

Exercise Ischemia Angina Physiology 119

HCPLive

JANUARY 14, 2024

A study compared the efficacy of febuxostat and benzbromarone in treating gout, emphasizing the lack of consensus in previous research and the need for future, well-designed studies.

Research 111

Research 111

Heart Sisters

JANUARY 14, 2024

Having severe symptoms dismissed by the doctors we turn to for help can feel as crushing as the physical suffering itself, says science writer Ed Yong - who believes that journalists can "clarify the unfathomable for people too sick to do it themselves.

COVID-19 94

COVID-19 94

HCPLive

JANUARY 14, 2024

In this discussion with E. James Song, MD, several unique clinical pearls for those in dermatology were described and had been drawn from Song’s Winter Clinical presentation.

105

105

ECG Weekly Workout

JANUARY 14, 2024

HPI: A 55-year-old man with no significant PMHx (on no medications) presents to the emergency department with right lower quadrant pain. He is afebrile on arrival, with mild sinus tachycardia. He is found to have perforated appendicitis and is admitted for operative intervention. The following routine preoperative ECG is obtained: Case ECG Before watching this week’s video.

Tachycardia 81

Tachycardia Sudden Cardiac Death 81

Medical Xpress - Cardiology

JANUARY 14, 2024

Acoramidis yields a significantly better four-step primary hierarchical outcome, including aspects of mortality and morbidity, than placebo for patients with transthyretin amyloid cardiomyopathy, according to a study published in the Jan. 11 issue of the New England Journal of Medicine.

Cardiomyopathy 75

Cardiomyopathy Outcomes 75

Frontiers in Cardiovascular Medicine

JANUARY 14, 2024

Background The objective of this study was to investigate the differences in presenting symptoms between patients with and without diabetes being diagnosed with an acute myocardial infarction (AMI). Methods A total of 5,900 patients with a first-time AMI were included into the analysis. All patients aged between 25 and 84 years were recorded by the population-based Myocardial Infarction Registry in Augsburg, Germany, between 2010 and 2017.

Myocardial Infarction 64

Myocardial Infarction Diabetes Chest Pain Risk Factors 64

Frontiers in Cardiovascular Medicine

JANUARY 14, 2024

Background Echocardiography-guided percutaneous intramyocardial alginate-hydrogel implantation (PIMAHI) is a novel treatment approach for heart failure (HF). We validated PIMAHI safety and efficacy in canine HF models. Methods Fourteen canines with HF [produced by coronary artery ligation, left ventricular ejection fraction (LVEF) < 35%] were randomised to PIMAHI treatment ( n  = 8) or controls ( n  = 6).

Heart Failure 64

Heart Failure Outcomes Bicuspid/Mitral Arrhythmia 64

ADN Center of Excellence

JANUARY 14, 2024

In the ever-evolving landscape of medical advancements, continuous education plays a pivotal role in shaping the expertise of healthcare professionals. Our recent Mitral Valve Training, held on January 10-11, emerged as a beacon of excellence, bringing together cardiologists from across the globe for an immersive experience. Today, we unravel the triumphs and highlights of this exceptional event that left an indelible mark on the journey of medical education.

Bicuspid/Mitral 59

Bicuspid/Mitral Anatomy Education Heart Valves 59

Frontiers in Cardiovascular Medicine

JANUARY 14, 2024

Background Surgery for type A aortic dissection (TAAD) is associated with high risk of mortality. Current risk scoring methods have a limited predictive accuracy. Methods Subjects were patients who underwent surgery for acute TAAD at 18 European centers of cardiac surgery from the European Registry of Type A Aortic Dissection (ERTAAD). Results Out of 3,902 patients included in the ERTAAD, 2,477 fulfilled the inclusion criteria.

Risk Factors 64

Risk Factors Hospital Aortic Ischemia 64

Medical Xpress - Cardiology

JANUARY 14, 2024

The use of the antipsychotic drugs quetiapine and haloperidol is associated with an increased risk of ventricular arrhythmias and sudden cardiac death (SCD) caused by drug-induced QT prolongation, reports a new study in Heart Rhythm.

Sudden Cardiac Death 56

Sudden Cardiac Death Heart Rhythm Arrhythmia 56

Frontiers in Cardiovascular Medicine

JANUARY 14, 2024

Objective Cardiac surgery in Congenital Heart Disease-Heterotaxy (CHD-HTX) patients often leads to increased postoperative airway complications. Abnormal respiratory ciliary function, resembling primary ciliary dyskinesia, has been observed. We expanded the sample size by retrospectively reviewing Ciliary Dysfunction (CD) in CHD-HTX patients to verify the increased risk of post-surgical respiratory complications.

Congenital Heart Disease 64

Congenital Heart Disease Congenital Heart Disease ICU 64

ADN Center of Excellence

JANUARY 14, 2024

In the heart of Adana, the Adana City Health Training and Research Center recently became the epicenter of groundbreaking advancements in medical education. Last week marked a significant milestone as the center of excellence for Transcatheter Aortic Valve Implantation (TAVI) procedures hosted a highly successful TAVI Masterclass. Spearheaded by the eminent Prof.

Research 52

Research Education Heart Valves Aortic valve 52

Frontiers in Cardiovascular Medicine

JANUARY 14, 2024

Introduction Statins remain the first-line treatment for secondary prevention of cardiovascular (CV) events, with lowering of low-density lipoprotein cholesterol (LDL-C) being their therapeutic target. Although LDL-C reduction significantly lowers CV risk, residual risk persists, even in patients with well-controlled LDL-C; thus, statin add-on agents that target pathways other than LDL-C, such as the omega-3 fatty acid eicosapentaenoic acid, may help to further reduce persistent CV risk in patie

Peripheral Arterial Disease 64

Peripheral Arterial Disease Cardiovascular Disease Cerebrovascular Disease Coronary Artery Disease 64

ADN Center of Excellence

JANUARY 14, 2024

In the ever-evolving landscape of medical advancements, continuous education plays a pivotal role in shaping the expertise of healthcare professionals. Our recent Mitral Valve Training, held on January 10-11, emerged as a beacon of excellence, bringing together cardiologists from across the globe for an immersive experience. Today, we unravel the triumphs and highlights of this exceptional event that left an indelible mark on the journey of medical education.

Bicuspid/Mitral 52

Bicuspid/Mitral Anatomy Education Heart Valves 52

Frontiers in Cardiovascular Medicine

JANUARY 14, 2024

Background The Occlutech Atrial Flow Regulator (AFR) is a self-expandable double-disc nitinol device with a central fenestration. Its use has been approved in the adult population with heart failure and described for pulmonary hypertension (PH). Only case reports and small series have been published about its use in the paediatric population and for congenital heart disease (CHD).

Congenital Heart Disease 59

Congenital Heart Disease Cardiomyopathy Congenital Heart Disease 59

All About Cardiovascular System and Disorders

JANUARY 14, 2024

Right Heart Catheterization in Tetralogy of Fallot With the availability of high resolution echocardiographic images and Doppler echocardiography, role of cardiac catheterization has come down in tetralogy of Fallot and other congenital heart diseases in general. Important risks for cardiac catheterization in a deeply cyanotic infant are the chance of precipitation of a cyanotic spell and thrombotic strokes due to hemoconcentration.

Congenital Heart Disease 52

Congenital Heart Disease Pulmonary Anatomy Congenital 52

Dr. S. Venkatesan MD

JANUARY 14, 2024

What will happen if you happen to thrombolyse   Wellen syndrome? Will evolve into STEMI by prothrombotic trigger of lytic agent ECG will get normalised with clinical stability in some Nothing happens. ECG will remain same. Worsen the situation in majority Will be severely reprimanded by your consultant and peers. Answer: 4 will be answer for most of us , while 2 and 3 is a lesser, but distinct possibility.

Anatomy 52

Anatomy Angina Thrombosis STEMI 52

HCPLive

JANUARY 14, 2024

A local corticosteroid burst followed by 0.18 mg FAi may be a useful adjuvant for the treatment of noninfectious uveitis, but not sufficient as solo therapy.

52

52

Journal of Cardiovascular Pharmacology

JANUARY 14, 2024

Pretreatment with an oral P2Y12 receptor blocker (before coronary angiography) vs. treatment in the catheterization laboratory has been a matter of debate in patients presenting with non-ST segment elevation myocardial infarction (NSTEMI). The primary aim of this study was to assess the impact of an immediate preloading strategy with ticagrelor on periprocedural myocardial injury in patients with NSTEMI treated with an early invasive strategy.

Myocardial Infarction 40

Myocardial Infarction Catheterization Laboratory Laboratory Hypertension 40

The American Journal of Cardiology

JANUARY 14, 2024

Publication date: Available online 14 January 2024 Source: The American Journal of Cardiology Author(s): Michaella Alexandrou, Athanasios Rempakos, Deniz Mutlu, Ahmed Al Ogaili, James W. Choi, Paul Poommipanit, Khaldoon Alaswad, Mir Babar Basir, Rhian Davies, Stewart Benton, Farouc A. Jaffer, Raj H. Chandwaney, Kathleen E. Kearney, Ahmed M. ElGuindy, Nidal Abi Rafeh, Omer Goktekin, Sevket Gorgulu, Jaikirshan J.

40

40

Frontiers in Cardiovascular Medicine

JANUARY 14, 2024

Background Treatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI) was introduced in 2002. Since then, TAVI has become the primary treatment approach worldwide for advanced-age patients and younger patients with severe comorbidities. We aimed to evaluate the changes in patient demographics, complications, and mortality rates within 13 years.

Aortic valve 111

Aortic valve Aortic Pacemaker Stenosis 111

The American Journal of Cardiology

JANUARY 14, 2024

Publication date: Available online 14 January 2024 Source: The American Journal of Cardiology Author(s): Stefano Nistri, Donato Mele, Giuseppe Tarantini

Aortic valve 40

Aortic valve Aortic Outcomes 40

The American Journal of Cardiology

JANUARY 14, 2024

Publication date: Available online 14 January 2024 Source: The American Journal of Cardiology Author(s): Michel Pompeu Sá, Ibrahim Sultan, Danny Chu

40

40